SP
BIO icon

SIH Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

SIH Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Buy
+2,000
New +$567K ﹤0.01% 227
2025
Q3 		– Sell
-10,000
Closed -$2.41M – 232
2025
Q2 		$2.41M Buy
+10,000
New +$2.36M 0.09% 70

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SIH Partners's BIO Position: Q2 2026 in Review

SIH Partners opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 2,000 shares worth $587K. The stake represents ﹤0.01% of the portfolio and ranks #227 among its holdings. This is a return to the name: SIH Partners previously reported a position in BIO as recently as Q2 2025.

SIH Partners first reported a position in BIO in Q2 2025 and has held it in 2 quarters since. The position peaked at $2.41M in Q2 2025. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • SIH Partners held 2,000 shares of Bio-Rad Laboratories Class A worth $587K as of Q2 2026.
  • Bio-Rad Laboratories Class A was a new SIH Partners position in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of SIH Partners's portfolio in Q2 2026, its #227 holding.
  • SIH Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2025 and has held it in 2 quarters since.
  • SIH Partners's Bio-Rad Laboratories Class A position peaked at $2.41M in Q2 2025.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.